329.40CHF+0.37%Mkt Cap: 269.24B CHFP/E: 21.10Last update: 2026-05-18
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas o…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Company
Market Cap269.24B CHF
Enterprise Value285.77B CHF
Revenue (TTM)63.36B CHF
Gross Profit46.71B CHF
Net Income (TTM)12.88B CHF
Revenue/Share79.59 CHF
Last Price329.40 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012032048
Valuation
P/E (Trailing)21.10
P/E (Forward)15.16
PEG1.44
EV/EBITDA11.88
EV/Revenue4.51
P/S4.17
P/B7.81
EPS (TTM)16.03
EPS (Forward)21.88
52W Range
256.4058% of range383.00
52W High383.00 CHF
52W Low256.40 CHF
Profitability
Gross Margin73.73%
Oper. Margin29.99%
EBITDA Margin37.95%
Profit Margin20.33%
ROE38.10%
ROA12.79%
Growth
Revenue Growth-0.40%
Earnings Growth171.30%
Cash Flow & Leverage
Operating CF18.85B CHF
CapEx (TTM)5.78B CHF
FCF Margin17.41%
FCF Yield4.10%
Net Debt17.71B CHF
Net Debt/EBITDA0.74
Balance Sheet
Debt/Equity0.98
Current Ratio1.38
Quick Ratio1.05
Book Value/Sh42.48 CHF
Cash/Share19.46 CHF
Dividends
Fwd Div Rate9.800 CHF
Trail. Div Rate9.800 CHF
Div. Yield2.95%
5Y Avg Yield3.04%
Payout Ratio60.47%
Ex-Div DateMar 12, 2026
Pay DateMar 31, 2025
Splits
Last Split100:1
Split DateMay 4, 2011
Analyst Consensus
Rating—
Target (Mean)367.00 CHF
Target Range340.00 CHF – 396.00 CHF
# Analysts3
Ownership
Shares Out.106.69M
Float652.94M
Insiders72.57%
Institutions10.30%
Technical
SMA 50329.28 (+0.0%)
SMA 200317.52 (+3.7%)
Beta0.33
S&P 52W Chg24.23%
Avg Vol (30d)28.70K
Avg Vol (10d)24.74K
Technical Indicators
RSI (14)51.0
MACD-0.9523
MACD Signal-1.4954
MACD Hist.+0.5431
BB Upper334.17 CHF
BB Middle327.94 CHF
BB Lower321.71 CHF
BB Width3.80%
ATR (14)6.751 CHF
Vol Ratio (20d)0.77x